K.J. Harrison & Partners’s Boston Scientific BSX Stock Holding History

K.J. Harrison & Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Sell	4,066 -42,717	-91%	-$3.42M	0.04%	213
2025 Q4	$4.46M	Buy	46,783 +4,374	+10%	+$429K	0.59%	49
2025 Q3	$4.08M	Sell	42,409 -12,000	-22%	-$1.24M	0.58%	49
2025 Q2	$5.84M	Buy	54,409 +25,016	+85%	+$2.53M	0.97%	27
2025 Q1	$2.97M	Sell	29,393 -4,857	-14%	-$489K	0.58%	54
2024 Q4	$3.06M	Sell	34,250 -35,050	-51%	-$3.09M	0.48%	60
2024 Q3	$6.1M	Buy	69,300 +20,000	+41%	+$1.58M	0.92%	27
2024 Q2	$3.8M	Hold	49,300	–	–	0.62%	44
2024 Q1	$3.38M	Buy	+49,300	New	+$3.17M	0.52%	57

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

K.J. Harrison & Partners's BSX Position: Q1 2026 in Review

K.J. Harrison & Partners reduced its Boston Scientific (BSX) stake by 91% in Q1 2026, selling an estimated $3.42M and leaving 4,066 shares worth $255K. The position accounts for 0.04% of the portfolio, ranked #213.

K.J. Harrison & Partners first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.1M in Q3 2024. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

K.J. Harrison & Partners held 4,066 shares of Boston Scientific worth $255K as of Q1 2026.
K.J. Harrison & Partners sold 42,717 Boston Scientific shares in Q1 2026, an estimated $3.42M.
Boston Scientific made up 0.04% of K.J. Harrison & Partners's portfolio in Q1 2026, its #213 holding.
K.J. Harrison & Partners first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
K.J. Harrison & Partners's Boston Scientific position peaked at $6.1M in Q3 2024.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on K.J. Harrison & Partners's 13F filing for Q1 2026, filed 28 Apr 2026.